Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

TAK-279 effectively reduces psoriasis symptoms and is safe.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

The new assay can help develop products for hair re-growth.

MC-1R in skin cells may influence inflammation and collagen production.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Berberine may reduce prostate enlargement by blocking inflammation.

M50054 may help treat hepatitis and hair loss from chemotherapy.

The new compound may be a safer alternative to finasteride for prostate protection.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.